Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-17T20:06:27.939Z Has data issue: false hasContentIssue false

Sudden sensorineural deafness and hormone replacement therapy

Published online by Cambridge University Press:  29 June 2007

David Strachan*
Affiliation:
Department of Otolaryngology, St. James' Beckett Street, Leeds, UK.
*
Address for correspondence: Mr D. R. Strachan, Department of Otolaryngolgy, St James' Hospital, Beckett Street, Leeds LS9 7TF
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Whilst the oral contraceptive pill (OC) has been implicated on a number oif occasions as a cause of sensorineural hearing loss, there are no published reports linking hormone replacement therapy (HRT) to otological symptoms. A case of sensorineural loss with tinnitus following commencement of HRT is described, followed by a discussion outlining the fundamental differences between the OC and HRT, thus expaining why a vascular aetiology is unlikely. It is hypothesized that otological symptoms in such cases may be due to the effect of oestrogens on electrolyte balance disturbing inner ear function and also a direct effect on the auditory pathways mediated in part by alterations in neurotransmitter receptor concentrations.

Information

Type
Clinical Records
Copyright
Copyright © JLO (1984) Limited 1996